HealtheUniverse Re-Releases Shareholder Letter Highlighting Adult Stem Cell Clinical Initiatives

COVINA, CA -- (MARKET WIRE) -- March 14, 2007 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, today re-released a letter to shareholders. In the letter, Chief Executive Officer Dr. Vipul Dev M.D. summarizes the Company’s recent accomplishments during the first few months of 2007 and cites key goals for Healtheuniverse’s adult stem cell and regenerative medicine clinical development programs.

MORE ON THIS TOPIC